Secondary prevention of coronary heart disease. A survey in an Italian primary care practice

被引:0
|
作者
Modesti, A. [1 ]
Del Papa, C. [1 ]
Modesti, L. [1 ]
Bartaloni, R. [1 ]
Galloni, V. [1 ]
Dell'Omo, G. [2 ]
Pedrinelli, R. [2 ]
机构
[1] Studio Associato Med Gen, Pontedera, Italy
[2] Univ Pisa, Dipartimento Cardiotorac & Vasc, I-56100 Pisa, Italy
来源
MINERVA CARDIOANGIOLOGICA | 2010年 / 58卷 / 02期
关键词
Coronary heart disease; prevention and control; drug therapy; Physicians; family; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; CHOLESTEROL; EPIDEMIOLOGY; GUIDELINES; NETWORK; STATINS; MEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. Management of patients with pre-existing coronary heart disease (CHD) relies for the most part on primary care physicians, an endeavour whose success is dependent upon acceptance and day-to-day application of guideline recommendations for secondary CHD prevention. The aim of this study is to analyze the status of secondary CHD prevention in an Italian primary care practice consisting of five partnered general practitioners attending 7006 subjects aged 15years or more (3137 males, 3869 females) in Pontedera, Tuscany. Methods. Retrieval of patients with history of CUD (previous myocardial infarction, [MA and stable angina) from computerized records of the 5987 (2735 men, 3252 women) subjects aged 35-85 years enlisted in the practice. Patients with myocardial infarction <3 months at the time of the query were excluded. Results. Search retrieved 153 (2.6%) subjects with history of CHD, 93 (3.4%) males and 60 (1.8%) females. Females were older and smoked more frequently than men. Antiplatelet drugs, beta-blockers, renin-angiotensin system bloc-kers and statins were prescribed in 84%, 56%, 66% and 68% of the ischemic patients. LDL cholesterol targets of 100 and 70 mg/dL were achieved in only 60(45%) and 11 (9%) respectively. Systolic blood pressure was above 140 mmHg in 25 out of 146 patients with available data. Conclusion. The surveys shows satisfactory uptake of guideline recommendations but also pitfalls in the implementation of secondary CHD prevention requirements. Targeted interventions on primary care physicians are critically needed to enhance further provider adherence to consensus guidelines for CHD risk reduction.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 50 条
  • [21] Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
    Bubnova, M. G.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (08): : 97 - 107
  • [22] A comparison of secondary prevention practice in poststroke and coronary heart disease patients
    Vanek, J.
    Mayer, O., Jr.
    Seidlerova, J.
    Bruthans, J.
    Kielbergerova, L.
    Wohlfahrt, P.
    Krajcoviechova, A.
    Filipovsky, J.
    Cifkova, R.
    [J]. PUBLIC HEALTH, 2016, 137 : 64 - 72
  • [23] Prevention of both osteoporosis and coronary heart disease in primary care
    Waine, C
    [J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1996, 50 (01): : 44 - 46
  • [24] Secondary prevention in coronary heart disease
    Haq, IU
    Minnis, RC
    Jackson, PR
    Yeo, WW
    Ramsay, LE
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 1996, 9 (05) : 363 - 371
  • [25] Secondary prevention of coronary heart disease
    Zafari, AM
    Wenger, NK
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1998, 79 (08): : 1006 - 1017
  • [26] The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women
    Tziomalos, Konstantinos
    Kakafika, Anna I.
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (10) : 1054 - 1062
  • [27] The role of antioxidative vitamins in primary and secondary prevention of coronary heart disease
    Biesalski, HK
    [J]. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 1999, 69 (03) : 179 - 186
  • [28] Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial
    Khunti, Kamlesh
    Stone, Margaret
    Paul, Sanjoy
    Baines, Jan
    Gisborne, Louise
    Farooqi, Azhar
    Luan, Xiujie
    Squire, Iain
    [J]. HEART, 2007, 93 (11) : 1398 - 1405
  • [29] PHARMACOLOGICAL TRIALS - PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    STAMLER, J
    [J]. PREVENTIVE MEDICINE, 1983, 12 (01) : 196 - 203
  • [30] Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease
    Tavridou, A.
    Efthimiadis, A.
    Efthimiadis, I.
    Paschalidou, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 485 - 489